Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Terns Pharmaceuticals Inc’s stock clocked out at $9.70, down -2.90% from its previous closing price of $9.99. In other words, the price has decreased by -$2.90 from its previous closing price. On the day, 1.19 million shares were traded. TERN stock price reached its highest trading level at $10.03 during the session, while it also had its lowest trading level at $9.56.
Ratios:
To gain a deeper understanding of TERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.85 and its Current Ratio is at 27.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on June 22, 2023, initiated with a Buy rating and assigned the stock a target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.
On May 31, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $23.ROTH MKM initiated its Buy rating on May 31, 2023, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 03 ’24 when Vivo Opportunity, LLC sold 138,066 shares for $6.20 per share. The transaction valued at 856,009 led to the insider holds 268,573 shares of the business.
Vivo Opportunity, LLC sold 101,480 shares of TERN for $674,842 on Apr 02 ’24. The 10% Owner now owns 272,722 shares after completing the transaction at $6.65 per share. On Apr 01 ’24, another insider, Vivo Opportunity, LLC, who serves as the 10% Owner of the company, sold 181,117 shares for $6.99 each. As a result, the insider received 1,266,008 and left with 275,772 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 646124736 and an Enterprise Value of 387141312.
Stock Price History:
The Beta on a monthly basis for TERN is -0.28, which has changed by 0.19164622 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $10.02, while it has fallen to a 52-week low of $3.26. The 50-Day Moving Average of the stock is 43.04%, while the 200-Day Moving Average is calculated to be 61.03%.
Shares Statistics:
It appears that TERN traded 1.11M shares on average per day over the past three months and 1346820 shares per day over the past ten days. A total of 64.58M shares are outstanding, with a floating share count of 42.98M. Insiders hold about 33.54% of the company’s shares, while institutions hold 76.42% stake in the company. Shares short for TERN as of 1719532800 were 2686113 with a Short Ratio of 2.41, compared to 1717113600 on 2129832. Therefore, it implies a Short% of Shares Outstanding of 2686113 and a Short% of Float of 4.71.
